2009
DOI: 10.1080/01443610802633940
|View full text |Cite
|
Sign up to set email alerts
|

Postmenopausal bleeding due to cervical involvement with Wegener's granulomatosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 9 publications
0
12
0
Order By: Relevance
“…To our knowledge, only 6 cases have been previously reported, [3][4][5][6][7][8] and the occurrence of cervical abnormalities as the first manifestation has been described in only a single case. 4 In a cohort of 158 patients with diagnosis of GPA, biopsy-proven granulomatosis of the cervix was reported in less than 1% of patients.…”
Section: Involvement Of Uterine Cervix As the First Manifestation Of mentioning
confidence: 69%
“…To our knowledge, only 6 cases have been previously reported, [3][4][5][6][7][8] and the occurrence of cervical abnormalities as the first manifestation has been described in only a single case. 4 In a cohort of 158 patients with diagnosis of GPA, biopsy-proven granulomatosis of the cervix was reported in less than 1% of patients.…”
Section: Involvement Of Uterine Cervix As the First Manifestation Of mentioning
confidence: 69%
“…Once studies with patients with MPA or EGPA (5) were removed, a total of 17 studies fulfilled all inclusion criteria and were selected for full-text evaluation and systematic review [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28]. After reviewing the 17 articles, 18 patients were identified as GPA with gynecological involvement (two patients reported by Stone et al) [12].…”
Section: Main Findingsmentioning
confidence: 99%
“…Genital tract involvement in GPA while unusual has been reported in the literature, [1][2][3][4][5][6] with most published cases showing varying responses to cyclophosphamide. A case reported by Bastone et al demonstrates near resolution of disease at 20 months post commencement of rituximab therapy.…”
mentioning
confidence: 99%